Induction of bone loss by bile duct ligation in rats

In Vivo

Volumn 15, Issue 4, 2001, Pages 281-287

  Mabuchi, M ^a   Kawamura, I ^a   Fushimi, M ^a   Inoue, T ^a   Takeshita, S ^a   Takakura, S ^a   Matsuo, M ^a   Tomoi, M ^a   Goto, T ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Bile duct ligation; Bone loss; Dietary restriction; Growth failure; IGF I

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; SOMATOMEDIN C;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT LIGATION; BILIARY CIRRHOSIS; BILIRUBIN BLOOD LEVEL; BONE ATROPHY; BONE DENSITY; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CORTICAL BONE; DIET RESTRICTION; DISEASE ASSOCIATION; FEMUR; FOOD INTAKE; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; TRABECULAR BONE;

EID: 0034763613     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Metabolic bone disease in primary biliary cirrhosis
2. Osteoporosis in chronic liver disease: Pathogenesis, risk factors, and management
3. Bone disease in cholestatic liver disease
4. Bone disorders in cholestatic liver diseases
5. Bone loss and reduced osteoblast function in primary biliary cirrhosis
6. Low bone turnover state in primary biliary cirrhosis
7. Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis
8. Insulin-like growth factor I stimulates growth in hypophysectomized rats
9. Resistance to the growth-promoting and metabolic effects of growth hormone in children with chronic liver disease
10. Insulin-like growth factor I stimulates bone turnover in osteoporosis
11. Insulin-like growth factors and their binding proteins: Biological actions
12. Insulin-like growth factors
13. Longitudinal bone growth in vitro: Effects of insulin-like growth factor I and growth hormone
14. In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats
15. Insulin-like growth factors I and II are present in the skeletal tissues of ten vertebrates
16. Nutritional regulation of insulin-like growth factor-I
17. Growth failure in cholestatic rats: The effect of malnutrition on insulin-like growth factor I
18. The decreased plasma concentrations of insulin-like growth factor-I in protein-restricted rats is not due to decreased numbers of growth hormone receptors on isolated hepatocytes
19. Response of the IGF-I system to prolonged undernutrition and its involvement in somatic and skeletal muscle growth retardation in rats
20. Prolonged bile duct obstruction: A new experimental model for cirrhosis in the rat
21. A quantitative analysis of the liver following ligation of the common bile duct
22. Histological and biochemical changes induced by total bile duct ligation in the rat
23. Plasma amino acid in long-term models for obstructive versus toxic liver injury in developing rats
24. Growth failure and decreased levels of insulin-like growth factor I in obstructive jaundice are reversed by bile diversion
25. Differential effects of malnutrition, bile duct ligation and galactosamine injection in young rats on serum levels and gene expression of IGF-binding proteins
26. Cytokines and the progression of liver damage in experimental bile duct ligation
27. Assessment of the skeletal status by peripheral quantitative computed tomography of the forearm: Short-term precision in vivo and comparison to dual X-ray absorptiometry
28. Advances in the noninvasive assessment of bone density, quality, and structure
29. Regional analysis of bone mineral density in the distal femur and proximal tibia using peripheral quantitative computed tomography in the rat in vivo
30. The clinical expression of primary biliary cirrhosis
31. Prevention and treatment of osteoporosis in primary biliary cirrhosis
32. Bone disease in biliary atresia: A not uncommon complication
33. Bone mineral analysis and X-ray examination of the bone in patients with biliary atresia
34. Bone changes and mineral metabolism disorders in rats with experimental liver cirrhosis
35. Effects of IGF-I treatment on osteopenia in rats with advanced liver cirrhosis
36. Biliary cirrhosis induces type IIx/b fiber atrophy in rat diaphragm and skeletak muscle, and decreases IGF-I mRNA in the liver but not in muscle
37. Growth hormone, insulin-like growth factor binding proteins 1 and 3 in chronic liver disease
38. Concentrations, release, and disposal of insulin-like growth factor (IGF)-biding protiens (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis
39. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but not required for postnatal body growth in mice
40. Normal growth and development in the absence of hepatic insulin-like growth factor I
41. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: Increased trabecular bone volume without increased osteoblast proliferation